Sales rise 20.18% to Rs 1201.11 crore
Net profit of Strides Pharma Science reported to Rs 93.23 crore in the quarter ended September 2024 as against net loss of Rs 131.34 crore during the previous quarter ended September 2023. Sales rose 20.18% to Rs 1201.11 crore in the quarter ended September 2024 as against Rs 999.43 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales1201.11999.43 20 OPM %18.5711.09 -PBDT169.2668.14 148 PBT118.738.03 1379 NP93.23-131.34 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "María Corina Machado and Edmundo González Urrutia")
 "Tata power")
 "result, q1, q2, q3, q4")
 "Sheikh Hasina, Sheikh, Hasina")
 "Delhi Metro")
